With license and library deals, biotech spreads its DNA
By GREGORY ZELLER // It’s been a banner month for Applied DNA Sciences, with two new deals both reaffirming the biotech’s scientific value and significantly extending its commercial reach. On…
Techmer PM
On cotton, new capital and comebacks to come
By GREGORY ZELLER // Capital infusions and superstar strategic advisors couldn’t save Applied DNA Sciences from another bottom-line beating in the first quarter of Fiscal 2017 – but the biotech appears ready to punch…